Cañete, Alyanah M.

HRN: 27-84-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/15/2026
03/22/2026
IV
335mg
Q6hours
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: